More articles from 5.1 Airway Pharmacology and Treatment

Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
Genki Kimura, Yuki Nishimoto, Keitaro Ueda, Takahiro Nakaoki, Takashi Masuko, Peter J. Barnes, Kazuhiro Ito, Yasuo Kizawa

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4896; DOI: 10.1183/13993003.congress-2016.PA4896
WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk
Anita I.R. Spanjer, Eline M. van Dijk, Jacobien A. Noordhoek, Corry-Anke Brandsma, Wim Timens, Dirkje S. Postma, Herman Meurs, Reinoud Gosens, Irene H. Heijink

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5067; DOI: 10.1183/13993003.congress-2016.PA5067
The combination of TNF-α neutralization and dexamethasone treatment restored the corticosteroid responsiveness in tobacco smoking mice
Yuki Nishimoto, Genki Kimura, Keitaro Ueda, Takahiro Nakaoki, Kazuhiro Ito, Yasuo Kizawa

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5065; DOI: 10.1183/13993003.congress-2016.PA5065
TRPM3: A regulator of airway sensory nerves and respiratory reflexes
Sara Bonvini, Maham Arshad, Michael A. Wortley, John J. Adcock, Eric Dubuis, Kassandra Kosmidou, Sarah A. Maher, Fisnik Shala, Joris Vriens, Thomas Voets, Mark A. Birrell, Maria G. Belvisi

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5070; DOI: 10.1183/13993003.congress-2016.PA5070
Anti-inflammatory activity of the bradykinin B₁R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey
Thierry Bouyssou, Birgit Jung, Peter Nickolaus, Jeff Duan, Feihong Dai, Henri Doods

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5063; DOI: 10.1183/13993003.congress-2016.PA5063
Neurokinin-1 receptor antagonism for the treatment of cough in lung cancer
Amelie Harle, Fiona Blackhall, Alex Molassiotis, Kim Holt, Rachel Dockry, Philip Russell, Katy Burns, Ryan Robinson, Mark Birrell, Maria Belvisi, Jaclyn Smith

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5060; DOI: 10.1183/13993003.congress-2016.PA5060
Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease
Krupesh Patel, Chrishan Samuel, Simon Royce

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4891; DOI: 10.1183/13993003.congress-2016.PA4891
Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate
Luigino Calzetta, Paola Rogliani, Ermanno Puxeddu, Josuel Ora, Francesco Facciolo, Maria Gabriella Matera, Mario Cazzola

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5057; DOI: 10.1183/13993003.congress-2016.PA5057
Effect of high, medium, and low molecular weight hyaluronan on inflammation and oxidative stress in an in vitro model of human nasal epithelial cells
Giusy D. Albano, Anna Bonanno, Luca Cavalieri, Eleonora Ingrassia, Caterina Di Sano, Liboria Siena, Loredana Riccobono, Rosalia Gagliardo, Mirella Profita

European Respiratory Journal Sep 2016, 48 (suppl 60) PA5064; DOI: 10.1183/13993003.congress-2016.PA5064
RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects
Leif Bjermer, Johnston Stewart, Katharine Abbott-Banner, Kenneth Newman

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4905; DOI: 10.1183/13993003.congress-2016.PA4905

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages

Contact us